1. Home
  2. ENSC vs BON Comparison

ENSC vs BON Comparison

Compare ENSC & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • BON
  • Stock Information
  • Founded
  • ENSC 2003
  • BON 2006
  • Country
  • ENSC United States
  • BON China
  • Employees
  • ENSC N/A
  • BON N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • ENSC Health Care
  • BON Health Care
  • Exchange
  • ENSC Nasdaq
  • BON Nasdaq
  • Market Cap
  • ENSC 5.2M
  • BON 5.9M
  • IPO Year
  • ENSC N/A
  • BON 2021
  • Fundamental
  • Price
  • ENSC $2.14
  • BON $1.52
  • Analyst Decision
  • ENSC
  • BON
  • Analyst Count
  • ENSC 0
  • BON 0
  • Target Price
  • ENSC N/A
  • BON N/A
  • AVG Volume (30 Days)
  • ENSC 84.6K
  • BON 110.0K
  • Earning Date
  • ENSC 08-13-2025
  • BON 09-26-2025
  • Dividend Yield
  • ENSC N/A
  • BON N/A
  • EPS Growth
  • ENSC N/A
  • BON N/A
  • EPS
  • ENSC N/A
  • BON 4.17
  • Revenue
  • ENSC $7,413,722.00
  • BON $23,844,556.00
  • Revenue This Year
  • ENSC N/A
  • BON $223.38
  • Revenue Next Year
  • ENSC $1,354.55
  • BON $18.82
  • P/E Ratio
  • ENSC N/A
  • BON $0.35
  • Revenue Growth
  • ENSC 415.58
  • BON N/A
  • 52 Week Low
  • ENSC $1.62
  • BON $1.14
  • 52 Week High
  • ENSC $14.67
  • BON $73.75
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 51.93
  • BON 64.50
  • Support Level
  • ENSC $2.03
  • BON $1.27
  • Resistance Level
  • ENSC $2.21
  • BON $1.57
  • Average True Range (ATR)
  • ENSC 0.09
  • BON 0.08
  • MACD
  • ENSC 0.01
  • BON 0.02
  • Stochastic Oscillator
  • ENSC 63.38
  • BON 83.33

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.

Share on Social Networks: